<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825482</article-id>
    <article-id pub-id-type="pmid">36353986</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac1019</article-id>
    <article-id pub-id-type="publisher-id">gkac1019</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9925-4574</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Dapeng</given-names>
        </name>
        <aff><institution>Wellcome Centre for Human Genetics, University of Oxford</institution>, <addr-line>Oxford OX3 7BN</addr-line>, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kumar</surname>
          <given-names>Vinod</given-names>
        </name>
        <aff><institution>Kennedy Institute for Rheumatology, University of Oxford</institution>, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Burnham</surname>
          <given-names>Katie L</given-names>
        </name>
        <aff><institution>Wellcome Sanger Institute</institution>, <addr-line>Cambridge</addr-line>, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4502-2209</contrib-id>
        <name>
          <surname>Mentzer</surname>
          <given-names>Alexander J</given-names>
        </name>
        <aff><institution>Wellcome Centre for Human Genetics, University of Oxford</institution>, <addr-line>Oxford OX3 7BN</addr-line>, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Marsden</surname>
          <given-names>Brian D</given-names>
        </name>
        <!--brian.marsden@cmd.ox.ac.uk-->
        <aff><institution>Kennedy Institute for Rheumatology, University of Oxford</institution>, <country country="GB">UK</country></aff>
        <aff><institution>Centre for Medicines Discovery, NDM, University of Oxford</institution>, <addr-line>Oxford</addr-line>, <addr-line>OX3 7BN</addr-line>, <country country="GB">UK</country></aff>
        <xref rid="COR2" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0377-5536</contrib-id>
        <name>
          <surname>Knight</surname>
          <given-names>Julian C</given-names>
        </name>
        <!--julian@well.ox.ac.uk-->
        <aff><institution>Wellcome Centre for Human Genetics, University of Oxford</institution>, <addr-line>Oxford OX3 7BN</addr-line>, <country country="GB">UK</country></aff>
        <aff><institution>Chinese Academy of Medical Science Oxford Institute, University of Oxford</institution>, <country country="GB">UK</country></aff>
        <aff><institution>NIHR Oxford Biomedical Research Centre</institution>, <addr-line>Oxford</addr-line>, <country country="GB">UK</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <on-behalf-of>on behalf of the COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium</on-behalf-of>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +44 1865 287651; Fax: +44 1865 287533; Email: <email>julian@well.ox.ac.uk</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Brian D. Marsden. Email: <email>brian.marsden@cmd.ox.ac.uk</email></corresp>
      <fn id="FN1">
        <p>COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium members listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Data 1</xref>.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-11-10">
      <day>10</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>10</day>
      <month>11</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D896</fpage>
    <lpage>D905</lpage>
    <history>
      <date date-type="accepted">
        <day>21</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>10</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>07</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac1019.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Advances in our understanding of the nature of the immune response to SARS-CoV-2 infection, and how this varies within and between individuals, is important in efforts to develop targeted therapies and precision medicine approaches. Here we present a database for the COvid-19 Multi-omics Blood ATlas (COMBAT) project, COMBATdb (<ext-link xlink:href="https://db.combat.ox.ac.uk" ext-link-type="uri">https://db.combat.ox.ac.uk</ext-link>). This enables exploration of multi-modal datasets arising from profiling of patients with different severities of illness admitted to hospital in the first phase of the pandemic in the UK prior to vaccination, compared with community cases, healthy controls, and patients with all-cause sepsis and influenza. These data include whole blood transcriptomics, plasma proteomics, epigenomics, single-cell multi-omics, immune repertoire sequencing, flow and mass cytometry, and cohort metadata. COMBATdb provides access to the processed data in a well-defined framework of samples, cell types and genes/proteins that allows exploration across the assayed modalities, with functionality including browse, search, download, calculation and visualisation via shiny apps. This advances the ability of users to leverage COMBAT datasets to understand the pathogenesis of COVID-19, and the nature of specific and shared features with other infectious diseases.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>University of Oxford COVID-19 Research Response Fund</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>NIHR Oxford Biomedical Research Centre</institution>
            <institution-id institution-id-type="DOI">10.13039/501100013373</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Wellcome Trust</institution>
            <institution-id institution-id-type="DOI">10.13039/100010269</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>090532/Z/09/Z</award-id>
        <award-id>203141/Z/16/Z</award-id>
        <award-id>206194</award-id>
        <award-id>108413/A/15/D</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Wellcome Trust Investigator Award</institution>
          </institution-wrap>
        </funding-source>
        <award-id>204969/Z/16/Z</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Medical Research Council</institution>
            <institution-id institution-id-type="DOI">10.13039/501100000265</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>MR/V002503/1</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Chinese Academy of Medical Sciences</institution>
            <institution-id institution-id-type="DOI">10.13039/501100005150</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Innovation Fund for Medical Science</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2018-I2M-2-002</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Kennedy Trust for Rheumatology Research</institution>
            <institution-id institution-id-type="DOI">10.13039/100016580</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="10"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Deep immune phenotyping including multi-omic profiling at single cell resolution advances our ability to understand the host response to infection, and how this may both enable recovery and where dysregulated, contribute directly to pathogenesis (<xref rid="B1" ref-type="bibr">1–5</xref>). Such profiling has been applied at unprecedented scale and depth during the COVID-19 pandemic. Technologies employed have included high resolution flow and mass cytometry, single cell transcriptomics, proteomics and epigenomics, proteomics, and metabolomics, with application primarily to blood (<xref rid="B6" ref-type="bibr">6–20</xref>) but also autopsy and lung samples (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>), bronchoalveolar lavage (<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>), nasopharyngeal and bronchial sampling (<xref rid="B25" ref-type="bibr">25</xref>). Such data can provide insights into mediators and processes driving disease, identify potential therapeutic targets and advance understanding of why some people become severely ill, highlighting opportunities for precision medicine (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B26" ref-type="bibr">26</xref>). Together with clinical and experimental approaches, this has advanced our understanding of disease pathogenesis in COVID-19 and in particular the nature of local and systemic immunopathology and dysregulation driving severe disease (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>). Here, we present COMBATdb (<ext-link xlink:href="https://db.combat.ox.ac.uk" ext-link-type="uri">https://db.combat.ox.ac.uk</ext-link>), a database to explore datasets arising from one such programme of work, the COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium (<xref rid="B8" ref-type="bibr">8</xref>).</p>
    <p>COMBAT recruited participants without prior vaccination or exposure history at the start of the pandemic in the UK, before widespread use of dexamethasone for severe disease, providing a unique viewpoint on the host response state. Individuals with COVID-19 were compared between those in the community and hospitalised cases with mild, severe and critical illness. It remains unclear the extent to which mechanisms are shared between patients with COVID-19 who develop life threatening organ dysfunction and those with all-cause sepsis and with critical illness arising from viral infections, notably influenza (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>). COMBAT provides datasets allowing comparison with these groups, and with healthy controls. The COMBAT datasets span a breadth of modalities linked to a given blood draw (sample), including whole blood mass cytometry and transcriptomics (total RNA-Seq); B and T cell repertoire sequencing; peripheral blood mononuclear cells (PBMC) assayed using single-cell RNA and repertoire sequencing with epitope measurements (Cellular Indexing of Transcriptomes and Epitopes by Sequencing, CITE-Seq), chromatin accessibility (scATAC-Seq) and flow cytometry; and plasma proteomics (timsTOF mass spectrometry and Luminex immunoassays). COMBATdb provides a web application upon a relational database to explore and access these datasets, specifically processed data and associated metadata, with tools to browse, calculate, and download results, together with visualisation via shiny apps.</p>
  </sec>
  <sec id="SEC2">
    <title>DATABASE CONTENTS</title>
    <p>COMBATdb contains the metadata, immune phenotyping and omics data reported by the COMBAT Consortium with a user-friendly interface to query, investigate and visualise the data (Figure <xref rid="F1" ref-type="fig">1</xref>). All data arising from any assay modality are organised through the unified COMBAT sample identifier system and can be linked via the sample IDs. Metadata for assay modalities, participants, samples, sampling timepoints, and processing are provided together with their connectivity. The database allows query entry points through specific cell types, genes/proteins and samples or through each assay modality. COMBATdb provides pre-calculated differential abundance analysis results based on optimised parameters, and supports real-time calculation for comparison between groups of samples based on the user-inputted options.</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Schematic summarising the main modules of COMBATdb.</p>
      </caption>
      <graphic xlink:href="gkac1019fig1" position="float"/>
    </fig>
  </sec>
  <sec id="SEC3">
    <title>METADATA: PARTICIPANTS, TIMEPOINTS, SAMPLES, MODALITIES AND SOURCES</title>
    <p>The five key terms relating to the metadata in COMBATdb are ‘participants’, ‘participant timepoints’, ‘samples’, ‘modalities’, and ‘sources’. We established the COMBAT patient and sample identifier system to ensure that all essential information was contained in the sample ID itself, including cohort, participant ID, recruitment site, sub-sample ID, sample type, derived sample type, processing site and batch (<xref rid="B8" ref-type="bibr">8</xref>). Based on this, the participant timepoint IDs and participant IDs can be deduced from the sample IDs, and all are robustly linked. ‘Modalities’ refer to datasets generated from the same type of samples (e.g. plasma), produced through the same assay platform (e.g. Luminex immunoassay) and analysed in the same data analysis workflow—in this example, giving rise to the ‘Proteomics: Luminex (plasma)’ modality (Figure <xref rid="F2" ref-type="fig">2A</xref>). For some platforms, such as single cell transcriptomics/proteomics assayed using CITE-Seq, there are multiple modalities arising following application to PBMCs: gene expression counts combined at minor subset, major subset and cell type level (‘CITE-Seq: GEX Pseudobulk’ modality); cell counts at minor subset, major subset and cell type level (‘CITE-Seq: Composition’ modality); B cell repertoire (‘CITE-Seq: Single-cell BCR’ modality) and T cell repertoire (‘CITE-Seq: Single-cell TCR’ modality). We have currently included one integrated modality (tensor decomposition) that was derived from cellular composition, gene expression, and plasma proteomics (<xref rid="B8" ref-type="bibr">8</xref>) using a sparse decomposition of arrays (SDA) algorithm (<xref rid="B31" ref-type="bibr">31</xref>) with loading scores and/or posterior inclusion probabilities available. The data from each of the 13 modalities has been processed through the specific pipelines of the primary analysis as described in the STAR Methods section of the published COMBAT paper (<xref rid="B8" ref-type="bibr">8</xref>) following best practice with optimal parameters, state-of-the-art tools and consensus annotations. In order to meet the broad range of requirements of using the data, different types of normalised data have been stored in the database for the same modality or different modalities (Table <xref rid="tbl1" ref-type="table">1</xref>). ‘Sources’ refers to the comparator group to which that sample belongs, including healthy volunteers, community COVID-19 cases, COVID-19 hospitalised mild, severe or critical, convalescent sampling from hospitalised cases, critical cases with influenza and all cause sepsis (hospitalised and convalescent) (Figure <xref rid="F2" ref-type="fig">2B</xref>).</p>
    <fig position="float" id="F2">
      <label>Figure 2.</label>
      <caption>
        <p>Examples of COMBATdb pages. (A–E) Lists of browsable (<bold>A</bold>) assay modalities (<bold>B</bold>) sources (comparator groups) (<bold>C</bold>) participants (<bold>D</bold>) genes (<bold>E</bold>) cell types. (<bold>F</bold>) Landing page for multiomics data single search mode and the results. (<bold>G</bold>) Example of results for samples from Flow Cytometry: FACS modality. (<bold>H</bold>) Landing page for compare functionality and the resulting enriched Reactome pathways for Proteomics: timsTOF modality. (<bold>I</bold>) List of browsable features and components for various data types on the landing page of tensor decomposition modality.</p>
      </caption>
      <graphic xlink:href="gkac1019fig2" position="float"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>The modalities and their associated data types</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Modality</th>
            <th rowspan="1" colspan="1">Data type</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Bulk RNA-Seq</td>
            <td rowspan="1" colspan="1">count, logcpm</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Proteomics: timsTOF</td>
            <td rowspan="1" colspan="1">intensity</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Proteomics: Luminex (plasma)</td>
            <td rowspan="1" colspan="1">fluorescence intensity, concentration</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Proteomics: Luminex (serum)</td>
            <td rowspan="1" colspan="1">fluorescence intensity, concentration</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Flow Cytometry: FACS</td>
            <td rowspan="1" colspan="1">cell frequency</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Mass Cytometry: CyTOF (global panel)</td>
            <td rowspan="1" colspan="1">cell frequency</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Mass Cytometry: CyTOF (granulocyte panel)</td>
            <td rowspan="1" colspan="1">cell marker expression</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CITE-Seq: GEX Pseudobulk</td>
            <td rowspan="1" colspan="1">count, residual, RPM</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CITE-Seq: Composition</td>
            <td rowspan="1" colspan="1">cell count, cell frequency</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Bulk Repertoire: BCR</td>
            <td rowspan="1" colspan="1">BCR metrics</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Bulk Repertoire: TCR</td>
            <td rowspan="1" colspan="1">TCR metrics</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CITE-Seq: Single-cell BCR</td>
            <td rowspan="1" colspan="1">chain locus, contig QC</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CITE-Seq: Single-cell TCR</td>
            <td rowspan="1" colspan="1">chain composition</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </sec>
  <sec id="SEC4">
    <title>FUNCTIONS FOR EXPLORING DATA</title>
    <p>The ‘Browse’ function enables the user to list all the entries of each metadata term (modalities, participants, participant timepoints, samples and sources) and explore linked information about other metadata terms related to the selected entry. We provide two advanced ways of exploring the samples on the sample details page. The first shows the breakdown of sample attributes (for example cohort) that have been stored in the database. The second displays all samples that possess the specific attribute. COMBATdb supports the browsing of key processed data from the major modalities for participants, participant timepoints and samples, allowing the users to interrogate the various types of data from the same sample, participant timepoint or participant. For example, for each participant, participant time point and sample users can rapidly have an overview of which of the 13 individual modalities are available and browse them (Figure <xref rid="F2" ref-type="fig">2C</xref>). In addition, we also provide ‘genes’ and ‘cell types’ as browsable terms (Figure <xref rid="F2" ref-type="fig">2D</xref>, <xref rid="F2" ref-type="fig">E</xref>). Specifically, the ‘genes’ function can link five different modalities where gene or protein expression can be measured and calculated, such as ‘Bulk RNA-Seq’, ‘Proteomics: timsTOF’, ‘Proteomics: Luminex (plasma)’, ‘Proteomics: Luminex (serum)’ and ‘CITE-Seq: GEX Pseudobulk’. The cross-referencing between transcriptomics and proteomics data was performed based on shared gene names. The three levels of resolution of cell types (‘Cell type’, ‘Major cell subset’ and ‘Minor cell subset’) include data from ‘CITE-Seq: GEX Pseudobulk’ and ‘CITE-Seq: Composition’.</p>
    <p>The ‘Search’ function supports search by metadata in three modes: single, multiple and customisable. For single and multiple mode, the search results will return detailed information about single or multiple terms from modalities, participants, participant timepoints, samples, sources, genes and cell types. Using the customisable mode generates a list of samples, participant timepoints or participants that are defined by a given modality and a given source. For multiomics data, ‘single mode - multiomics data’ searches for a single participant, participant timepoint, sample, gene or cell type and returns the results of multiomics data on the same page, which enhances the comparison capability of cross modality data (Figure <xref rid="F2" ref-type="fig">2F</xref>). The ‘cell type’ page will display the cell types that are associated with the five modalities involving specific cell types arising from flow cytometry, mass cytometry and CITE-Seq (‘Flow Cytometry: FACS’, ‘Mass Cytometry: CyTOF (global panel)’, ‘Mass Cytometry: CyTOF (granulocyte panel)’, ‘CITE-Seq: GEX Pseudobulk’ and ‘CITE-Seq: Composition’).</p>
    <p>The ‘Primary’ function offers a way to access the data from each modality with different layouts for different modalities of data (Figure <xref rid="F2" ref-type="fig">2G</xref>). For gene/protein-oriented modalities, the landing page will be a selection of genes/proteins, and the user can further navigate to see the expression values for all samples for the gene/protein of interest. For the modalities involved with cell types, the user can choose the cell type first and then explore the data for all samples from a specific cell type. ‘CITE-Seq: GEX Pseudobulk’ is an exceptional case where both genes and cell types are present, and the data are organised in the order genes to cell types to samples.</p>
    <p>The ‘Compare’ function provides pre-calculated differential abundance analysis tables across two comparator groups of samples under the cut-offs of FDR &lt; 0.05 and fold change &gt; 1.5 for 7 out of 8 modalities. More stringent cut-offs (FDR &lt; 0.01 and fold change &gt; 2) have been applied for the ‘CITE-Seq: GEX Pseudobulk’ modality. For some of the modalities, this function offers functional analysis using Gene Ontology (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>) terms and Reactome pathways (<xref rid="B34" ref-type="bibr">34</xref>) under FDR &lt; 0.05 (Figure <xref rid="F2" ref-type="fig">2H</xref>). In particular cases, two source groups can be further combined to form a new source group such as ‘COVID_IP_severe_and_COVID_IP_critical’ that represents the merged group of ‘COVID_IP_severe’ and ‘COVID_IP_critical’.</p>
    <p>The ‘Integrative’ function provides a high-level picture of multimodal data analysis integration. The ‘Tensor decomposition’ module offers two ways of starting to query the data, through either feature or SDA component. Each component comprises vectors of scores (loadings) indicating the contribution of individual features (cell types, genes, or proteins) linked by that component (Figure <xref rid="F2" ref-type="fig">2I</xref>). This design allows the user to compare loading scores and/or posterior inclusion probabilities for different features for the same component and data type, or for different components for the same feature and data type.</p>
    <p>The ‘Download’ function provides two tables that contain information such as dataset ID, description and accession number as well as links to download the key processed datasets for this database and the COMBAT project more broadly, and how to access raw datasets.</p>
  </sec>
  <sec id="SEC5">
    <title>SHINY APPS</title>
    <p>We have prepared shiny apps (using the R shiny package) for a selection of modalities to allow differential abundance analysis and data visualisation.</p>
    <p>The differential abundance analysis module accepts the user-provided options of two comparator groups (case versus control), sample inclusion strategy, covariates, FDR threshold and fold change threshold. The results are in the form of tables, volcano plots and boxplots. We provide three different strategies for inclusion, namely ‘all samples’, ‘priority samples’ (the first sample available at the maximum sampled severity for each patient) and ‘priority samples at maximum severity’ (first sample taken at the maximum clinical severity for that patient) to give user flexibility in the analysis. Covariates such as ‘age and sex’, ‘age’ and ‘none’ are adjusted for in the differential abundance analysis by defining the appropriate design matrix to fit the linear model in edgeR package (<xref rid="B35" ref-type="bibr">35</xref>) or limma package (<xref rid="B36" ref-type="bibr">36</xref>) except for ‘Proteomics: Luminex (plasma)’ and ‘Proteomics: Luminex (serum)’ where we use t-test, and for ‘Bulk Repertoire: BCR’, ‘Bulk Repertoire: TCR’ and ‘CITE-Seq: Single-cell TCR’ the Wilcoxon test. Although the data in the differential abundance table are calculated from the selected two groups of samples, the boxplots can be used to visually assess the abundance pattern across all source groups and direction of abundance changes for a specific gene, protein or cell cluster. For the cell type relevant modalities, we also provide the options of cell population or cell group resolution to add more levels to explore the data. To increase the readability of the name labels, we only show the top 20 most significant genes, proteins or cell clusters in each volcano plot.</p>
    <p>For the data visualisation module, we adopted high dimensional reduction techniques to generate principal component analysis (PCA) plots, correlation plots, loadings plots and heatmaps based on the user defined dimension for X axis, dimension for Y axis, sample inclusion strategy and covariates. Only source groups that contain at least 3 samples have been retained for further analysis and are displayed in the plots. For ‘Flow Cytometry: FACS’ and ‘Mass Cytometry: CyTOF (global panel)’, we use the CATALYST package (<xref rid="B37" ref-type="bibr">37</xref>) to prepare the data that are used to produce the PCA plots and loadings plots. For other modalities, we exploit the prcomp function and ggplot2 package to compute the PCA and make the PCA plots. To improve the visibility of labels on loadings plots, we only display the gene names for the points with larger loading scores in at least one of the two axes. For the tensor decomposition analysis, users can visualise the data by selecting the component of interest and choosing the posterior inclusion probability and two types of charts (boxplots and barplots) will be generated accordingly. The boxplot shows the general trends of each patient source group in terms of loading scores while the barplot for cell types for expression indicates the loading scores for whole blood and eight cell types (haematopoietic stem (and progenitor) cells, plasmablasts, natural killer cells, platelets platelet/CD34- megakaryocyte progenitor cells, B cells, T cells, mononuclear phagocytes, erythrocytes). The remaining barplots present the loading scores of cell types, proteins and genes whose corresponding posterior inclusion probability is no less than the given cut-off in an ascending order. In particular, only the bottom 50 genes and top 50 genes according to their loading score rank are shown for the gene barplot to ensure the visibility of gene names. Collectively, this module will support observation of the patterns of each source comparator group of samples and identification of the extent of contribution of each feature to each component.</p>
  </sec>
  <sec id="SEC6">
    <title>IMPLEMENTATION</title>
    <p>In anticipation of further data and modalities becoming available as part of COMBAT using existing or new samples, we adopted a modular and scalable philosophy in designing and developing COMBATdb. For the database schema, we created a number of MySQL tables to contain the metadata and modality data in a highly efficient manner. In brief, we have separate tables for modality, participant, participant timepoint, sample, source, gene and cell type. The key linker table is the many-to-many ‘modality2sample’ table. Each modality has an independent table for ‘primary’ and ‘compare’ function. To expedite data queries, indices have been created on certain columns of the data table. To mitigate against SQL injection security risks, we employed prepared statements throughout the platform. All the tables in the interface are searchable, sortable, and downloadable. To improve the performance of R shiny apps, we stored the input data in R object files that have been sufficiently processed and, in this way, the response time of running shiny apps is significantly reduced to an acceptable time period.</p>
    <sec id="SEC6-1">
      <title>Use case— exploring datasets to identify novel biomarkers</title>
      <p>Here we briefly illustrate an example of how the data can be explored within and across the multi-omic datasets. An important research question is the identification of potential biomarkers in COVID-19 for more severe disease amongst hospitalised patients. Plasma proteins are often used for point of care testing in other disease settings. A global overview of the major components of variance in all assayed plasma proteins comparing all participants is possible by principal components analysis using the ‘Visualisation’ function for timsTOF (Figure <xref rid="F3" ref-type="fig">3A</xref>). This shows separation along the largest component of variance (PC1) by comparator group (broadly a gradient between healthy, mild and most severely ill patients) with a number of proteins of potential interest contributing to PC1 on the PCA loadings plot. For example the adipokine leucine rich alpha-2 glycoprotein (LRG1) has the fourth highest loading score after serum amyloid proteins and C-reactive protein (CRP) (Figure <xref rid="F3" ref-type="fig">3B</xref>, <xref rid="F3" ref-type="fig">C</xref>). This can also be explored directly within the timsTOF modality using the shiny app, generating a volcano plot for all assayed plasma proteins comparing hospitalised COVID-19 patients with critical vs mild disease (Figure <xref rid="F3" ref-type="fig">3D</xref>). This shows that LRG1 is more abundant in critical COVID-19 patients (FDR = 0.009 and log<sub>2</sub>FC = 0.88), consistent with its role in innate immunity including as an inducible upstream modulator of TGFβ signalling (<xref rid="B38" ref-type="bibr">38</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Examples of analysis modules in shiny apps. (A–E) Plasma proteomics: timsTOF modality (<bold>A</bold>) options on the visualisation module (B, C) analysis generated from ‘One priority sample at maximum severity per individual’ (<bold>B</bold>) principal component analysis (PCA) plot coloured by source comparator groups (<bold>C</bold>) PCA loadings plot labelled by protein names. (<bold>D</bold>) Volcano plot based on the results from differential abundance analysis between COVID-19 (critical) and COVID-19 (mild). (<bold>E</bold>) Boxplot for the protein expression levels of a given protein (LRG1) grouped by source comparator groups. (<bold>F</bold>) Boxplot of LRG1 from ‘Bulk RNA-Seq modality’. (<bold>G</bold>) Boxplot of LRG1 from ‘CITE-Seq: GEX pseudobulk modality’ with cell group resolution ‘cell type’ and cell cluster name ‘MNP’ (mononuclear phagocytes).</p>
        </caption>
        <graphic xlink:href="gkac1019fig3" position="float"/>
      </fig>
      <p>LRG1 protein abundance can also be visualised using box plots across COVID-19 critical and mild patients, and other comparator groups (Figure <xref rid="F3" ref-type="fig">3E</xref>). To explore this protein further at a multi-omic level, the total RNA-Seq of whole blood dataset can be interrogated by the shiny app. This shows differential expression of <italic toggle="yes">LRG1</italic> between COVID-19 critical and mild cases (FDR = 0.00003 and log<sub>2</sub>FC = 1.51) (Figure <xref rid="F3" ref-type="fig">3F</xref>) which can be resolved to specific cell types form the single cell CITE-Seq data, for example mononuclear phagocytes (FDR = 0.008 and log<sub>2</sub>FC = 1.38) (Figure <xref rid="F3" ref-type="fig">3G</xref>). The different omic datasets can also be combined and interrogated using tensor decomposition. This shows that component 171 is most strongly associated with COVID-19 severity (<xref rid="B8" ref-type="bibr">8</xref>) and further highlights LRG1. The component can be visualised using the shiny app (Figure <xref rid="F4" ref-type="fig">4A</xref>) including box plots of loading scores by source comparator group (Figure <xref rid="F4" ref-type="fig">4B</xref>), with contributing cell types to the tensor component in terms of gene expression involving mononuclear phagocytes and to a lesser extent whole blood (Figure <xref rid="F4" ref-type="fig">4C</xref>), plasma proteins including SAA1/2, CRP, SERPINA3 and LRG1 (Figure <xref rid="F4" ref-type="fig">4D</xref>) and differential gene expression (Figure <xref rid="F4" ref-type="fig">4E</xref>).</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Integrative analysis using tensor decomposition. (<bold>A</bold>) Options within the visualisation module of the tensor decomposition modality. (B–E) Tensor decomposition shiny app showing (<bold>B</bold>) boxplot of loading scores of samples grouped by comparator group sources (<bold>C</bold>) barplot of loading scores for nine cell types for expression (<bold>D</bold>) barplot of loading scores for timsTOF proteins (<bold>E</bold>) barplot of loading scores of genes.</p>
        </caption>
        <graphic xlink:href="gkac1019fig4" position="float"/>
      </fig>
      <p>This example highlights the way the COMBAT datasets can be explored within COMBATdb, and a particular example involving LRG1 which adds to evidence for its potential utility as a biomarker and therapeutic target in a variety of diseases (<xref rid="B38" ref-type="bibr">38</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC7">
    <title>CONCLUSIONS</title>
    <p>Multi-omics and associated deep immunological profiling generate substantive high dimensional datasets, requiring careful attention to data management and informatics to allow effective databasing and maximise downstream utility of datasets. On behalf of the COMBAT Consortium, we have presented COMBATdb, a relational database that includes data across modalities generated from a unified set of samples. COMBATdb utilises key terms such as samples, genes/proteins and cell types to organise the various types of data in a user-friendly manner. It utilises cutting-edge bioinformatics tools such as R shiny apps together with other mainstream R packages to establish a flexible, intuitive and interactive visualisation platform that includes a set of user-provided options compatible with the experimental design and intrinsic data structure. The datasets in COMBATdb have been processed and standardised by following the best practice in each omics domain, the organisation of datasets in each modality supporting reanalysis and exploration of specific scientific questions. COMBATdb provides different approaches to explore the datasets from different angles to validate or complement the results of single analysis, including the integrative analysis of multiple omics datasets. Further interactive data visualisation is available at <ext-link xlink:href="https://mlv.combat.ox.ac.uk/" ext-link-type="uri">https://mlv.combat.ox.ac.uk/</ext-link> (<xref rid="B8" ref-type="bibr">8</xref>). Future work will incorporate new assays on existing and new samples, and look to support meta-analysis involving comparable studies. A variety of databases and webservers leverage multi-omics data in diverse areas of disease and biology including aging processes (<xref rid="B39" ref-type="bibr">39</xref>), cancer (<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>), biological networks (<xref rid="B42" ref-type="bibr">42</xref>), human microbiome (<xref rid="B43" ref-type="bibr">43</xref>), disease associations (<xref rid="B44" ref-type="bibr">44</xref>), host responses to viral infection (<xref rid="B45" ref-type="bibr">45</xref>) and specifically COVID-19 (<xref rid="B46" ref-type="bibr">46</xref>,<xref rid="B47" ref-type="bibr">47</xref>). We envisage that COMBATdb, as part of the COMBAT project (<xref rid="B8" ref-type="bibr">8</xref>), will support investigation of COVID-19 and other infectious diseases, and hope that the framework built here will facilitate the development of other multi-omics databases.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC8">
    <title>DATA AVAILABILITY</title>
    <p>COMBATdb is hosted at <ext-link xlink:href="https://db.combat.ox.ac.uk" ext-link-type="uri">https://db.combat.ox.ac.uk</ext-link>.</p>
    <p>Details of accession numbers for deposited data at Zenodo (<ext-link xlink:href="https://doi.org/10.5281/zenodo.6120249" ext-link-type="uri">https://doi.org/10.5281/zenodo.6120249</ext-link>) and European Genome Phenome Archive (EGAS00001005493) and ProteomeXchange Consortium via the PRIDE partner repository (PXD023175) are provided within the source publication (<xref rid="B8" ref-type="bibr">8</xref>) and COMBATdb.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac1019_Supplemental_File</label>
      <media xlink:href="gkac1019_supplemental_file.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We thank all participating patients and volunteers. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</p>
  </ack>
  <sec id="SEC9">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac1019#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC10">
    <title>FUNDING</title>
    <p>University of Oxford COVID-19 Research Response Fund; NIHR Oxford Biomedical Research Centre; Wellcome Trust [090532/Z/09/Z, 203141/Z/16/Z] to core facilities Wellcome Centre for Human Genetics; J.C.K. is supported by a Wellcome Trust Investigator Award [204969/Z/16/Z]; Medical Research Council [MR/V002503/1]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science [2018-I2M-2-002]; NIHR Oxford Biomedical Research Centre; B.D.M. is supported by the Kennedy Trust for Rheumatology Research; Wellcome Sanger Institute is supported by core funding from the Wellcome Trust [206194, 108413/A/15/D]. Funding for open access charge: Wellcome Trust.</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Dapeng Wang, National Heart and Lung Institute, Imperial College London, London, SW3 6LY, UK.</p>
  </notes>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ginhoux</surname><given-names>F.</given-names></string-name>, <string-name><surname>Yalin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Dutertre</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Amit</surname><given-names>I.</given-names></string-name></person-group><article-title>Single-cell immunology: past, present, and future</article-title>. <source>Immunity</source>. <year>2022</year>; <volume>55</volume>:<fpage>393</fpage>–<lpage>404</lpage>.<pub-id pub-id-type="pmid">35263567</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chi</surname><given-names>H.</given-names></string-name></person-group><article-title>Systems immunology: integrating multi-omics data to infer regulatory networks and hidden drivers of immunity</article-title>. <source>Curr. Opin. Syst. Biol.</source><year>2019</year>; <volume>15</volume>:<fpage>19</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">32789283</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eckhardt</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hultquist</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Kaake</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>Huttenhain</surname><given-names>R.</given-names></string-name>, <string-name><surname>Krogan</surname><given-names>N.J.</given-names></string-name></person-group><article-title>A systems approach to infectious disease</article-title>. <source>Nat. Rev. Genet.</source><year>2020</year>; <volume>21</volume>:<fpage>339</fpage>–<lpage>354</lpage>.<pub-id pub-id-type="pmid">32060427</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwok</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Mentzer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Knight</surname><given-names>J.C.</given-names></string-name></person-group><article-title>Host genetics and infectious disease: new tools, insights and translational opportunities</article-title>. <source>Nat. Rev. Genet.</source><year>2021</year>; <volume>22</volume>:<fpage>137</fpage>–<lpage>153</lpage>.<pub-id pub-id-type="pmid">33277640</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karczewski</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Snyder</surname><given-names>M.P.</given-names></string-name></person-group><article-title>Integrative omics for health and disease</article-title>. <source>Nat. Rev. Genet.</source><year>2018</year>; <volume>19</volume>:<fpage>299</fpage>–<lpage>310</lpage>.<pub-id pub-id-type="pmid">29479082</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Unterman</surname><given-names>A.</given-names></string-name>, <string-name><surname>Sumida</surname><given-names>T.S.</given-names></string-name>, <string-name><surname>Nouri</surname><given-names>N.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>A.Y.</given-names></string-name>, <string-name><surname>Gasque</surname><given-names>V.</given-names></string-name>, <string-name><surname>Schupp</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Asashima</surname><given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Cosme</surname><given-names>C.</given-names><suffix>Jr</suffix></string-name><etal>et al</etal>.</person-group><article-title>Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19</article-title>. <source>Nat. Commin.</source><year>2022</year>; <volume>13</volume>:<fpage>440</fpage>.</mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stephenson</surname><given-names>E.</given-names></string-name>, <string-name><surname>Reynolds</surname><given-names>G.</given-names></string-name>, <string-name><surname>Botting</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Calero-Nieto</surname><given-names>F.J.</given-names></string-name>, <string-name><surname>Morgan</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Tuong</surname><given-names>Z.K.</given-names></string-name>, <string-name><surname>Bach</surname><given-names>K.</given-names></string-name>, <string-name><surname>Sungnak</surname><given-names>W.</given-names></string-name>, <string-name><surname>Worlock</surname><given-names>K.B.</given-names></string-name>, <string-name><surname>Yoshida</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Single-cell multi-omics analysis of the immune response in COVID-19</article-title>. <source>Nat. Med.</source><year>2021</year>; <volume>27</volume>:<fpage>904</fpage>–<lpage>916</lpage>.<pub-id pub-id-type="pmid">33879890</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><collab>COMBAT Consortium</collab><article-title>A blood atlas of COVID-19 defines hallmarks of disease severity and specificity</article-title>. <source>Cell</source>. <year>2022</year>; <volume>185</volume>:<fpage>916</fpage>–<lpage>938</lpage>.<pub-id pub-id-type="pmid">35216673</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bernardes</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Mishra</surname><given-names>N.</given-names></string-name>, <string-name><surname>Tran</surname><given-names>F.</given-names></string-name>, <string-name><surname>Bahmer</surname><given-names>T.</given-names></string-name>, <string-name><surname>Best</surname><given-names>L.</given-names></string-name>, <string-name><surname>Blase</surname><given-names>J.I.</given-names></string-name>, <string-name><surname>Bordoni</surname><given-names>D.</given-names></string-name>, <string-name><surname>Franzenburg</surname><given-names>J.</given-names></string-name>, <string-name><surname>Geisen</surname><given-names>U.</given-names></string-name>, <string-name><surname>Josephs-Spaulding</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Longitudinal Multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19</article-title>. <source>Immunity</source>. <year>2020</year>; <volume>53</volume>:<fpage>1296</fpage>–<lpage>1314</lpage>.<pub-id pub-id-type="pmid">33296687</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Su</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Baloni</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>D.</given-names></string-name>, <string-name><surname>Pavlovitch-Bedzyk</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Duvvuri</surname><given-names>V.R.</given-names></string-name>, <string-name><surname>Ng</surname><given-names>R.H.</given-names></string-name>, <string-name><surname>Choi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19</article-title>. <source>Nat. Biotechnol.</source><year>2022</year>; <volume>40</volume>:<fpage>110</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">34489601</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schulte-Schrepping</surname><given-names>J.</given-names></string-name>, <string-name><surname>Reusch</surname><given-names>N.</given-names></string-name>, <string-name><surname>Paclik</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bassler</surname><given-names>K.</given-names></string-name>, <string-name><surname>Schlickeiser</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Kramer</surname><given-names>B.</given-names></string-name>, <string-name><surname>Krammer</surname><given-names>T.</given-names></string-name>, <string-name><surname>Brumhard</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bonaguro</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Severe COVID-19 is marked by a dysregulated myeloid cell compartment</article-title>. <source>Cell</source>. <year>2020</year>; <volume>182</volume>:<fpage>1419</fpage>–<lpage>1440</lpage>.<pub-id pub-id-type="pmid">32810438</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname><given-names>B.</given-names></string-name>, <string-name><surname>Yi</surname><given-names>X.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Bi</surname><given-names>X.</given-names></string-name>, <string-name><surname>Du</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Quan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>R.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Proteomic and metabolomic characterization of COVID-19 patient sera</article-title>. <source>Cell</source>. <year>2020</year>; <volume>182</volume>:<fpage>59</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">32492406</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ning</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Han</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zou</surname><given-names>X.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Bie</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Plasma proteomics identify biomarkers and pathogenesis of COVID-19</article-title>. <source>Immunity</source>. <year>2020</year>; <volume>53</volume>:<fpage>1108</fpage>–<lpage>1122</lpage>.<pub-id pub-id-type="pmid">33128875</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Silvin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Chapuis</surname><given-names>N.</given-names></string-name>, <string-name><surname>Dunsmore</surname><given-names>G.</given-names></string-name>, <string-name><surname>Goubet</surname><given-names>A.G.</given-names></string-name>, <string-name><surname>Dubuisson</surname><given-names>A.</given-names></string-name>, <string-name><surname>Derosa</surname><given-names>L.</given-names></string-name>, <string-name><surname>Almire</surname><given-names>C.</given-names></string-name>, <string-name><surname>Henon</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kosmider</surname><given-names>O.</given-names></string-name>, <string-name><surname>Droin</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19</article-title>. <source>Cell</source>. <year>2020</year>; <volume>182</volume>:<fpage>1401</fpage>–<lpage>1418</lpage>.<pub-id pub-id-type="pmid">32810439</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Su</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Lausted</surname><given-names>C.</given-names></string-name>, <string-name><surname>Choi</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dai</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Voillet</surname><given-names>V.</given-names></string-name>, <string-name><surname>Duvvuri</surname><given-names>V.R.</given-names></string-name>, <string-name><surname>Scherler</surname><given-names>K.</given-names></string-name>, <string-name><surname>Troisch</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Multi-Omics resolves a sharp disease-state shift between mild and moderate COVID-19</article-title>. <source>Cell</source>. <year>2020</year>; <volume>183</volume>:<fpage>1479</fpage>–<lpage>1495</lpage>.<pub-id pub-id-type="pmid">33171100</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>You</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Qin</surname><given-names>E.Q.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>P.</given-names></string-name></person-group><article-title>Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19</article-title>. <source>Nat. Cell Biol.</source><year>2021</year>; <volume>23</volume>:<fpage>620</fpage>–<lpage>630</lpage>.<pub-id pub-id-type="pmid">34108657</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ren</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wen</surname><given-names>W.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>W.</given-names></string-name>, <string-name><surname>Su</surname><given-names>B.</given-names></string-name>, <string-name><surname>Cai</surname><given-names>P.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas</article-title>. <source>Cell</source>. <year>2021</year>; <volume>184</volume>:<fpage>1895</fpage>–<lpage>1913</lpage>.<pub-id pub-id-type="pmid">33657410</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mathew</surname><given-names>D.</given-names></string-name>, <string-name><surname>Giles</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>Oldridge</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Greenplate</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Alanio</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kuri-Cervantes</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pampena</surname><given-names>M.B.</given-names></string-name>, <string-name><surname>D’Andrea</surname><given-names>K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications</article-title>. <source>Science</source>. <year>2020</year>; <volume>369</volume>:<fpage>eabc8511</fpage>.<pub-id pub-id-type="pmid">32669297</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.M.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Song</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xia</surname><given-names>P.</given-names></string-name>, <string-name><surname>Fu</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Single-cell landscape of immunological responses in patients with COVID-19</article-title>. <source>Nat. Immunol.</source><year>2020</year>; <volume>21</volume>:<fpage>1107</fpage>–<lpage>1118</lpage>.<pub-id pub-id-type="pmid">32788748</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>P.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Bai</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>K.</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The trans-omics landscape of COVID-19</article-title>. <source>Nat. Comm.</source><year>2021</year>; <volume>12</volume>:<fpage>4543</fpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delorey</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Ziegler</surname><given-names>C.G.K.</given-names></string-name>, <string-name><surname>Heimberg</surname><given-names>G.</given-names></string-name>, <string-name><surname>Normand</surname><given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Segerstolpe</surname><given-names>A.</given-names></string-name>, <string-name><surname>Abbondanza</surname><given-names>D.</given-names></string-name>, <string-name><surname>Fleming</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Subramanian</surname><given-names>A.</given-names></string-name>, <string-name><surname>Montoro</surname><given-names>D.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets</article-title>. <source>Nature</source>. <year>2021</year>; <volume>595</volume>:<fpage>107</fpage>–<lpage>113</lpage>.<pub-id pub-id-type="pmid">33915569</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Melms</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Biermann</surname><given-names>J.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>A.</given-names></string-name>, <string-name><surname>Tagore</surname><given-names>S.</given-names></string-name>, <string-name><surname>Katsyv</surname><given-names>I.</given-names></string-name>, <string-name><surname>Rendeiro</surname><given-names>A.F.</given-names></string-name>, <string-name><surname>Amin</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Schapiro</surname><given-names>D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A molecular single-cell lung atlas of lethal COVID-19</article-title>. <source>Nature</source>. <year>2021</year>; <volume>595</volume>:<fpage>114</fpage>–<lpage>119</lpage>.<pub-id pub-id-type="pmid">33915568</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grant</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Morales-Nebreda</surname><given-names>L.</given-names></string-name>, <string-name><surname>Markov</surname><given-names>N.S.</given-names></string-name>, <string-name><surname>Swaminathan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Querrey</surname><given-names>M.</given-names></string-name>, <string-name><surname>Guzman</surname><given-names>E.R.</given-names></string-name>, <string-name><surname>Abbott</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Donnelly</surname><given-names>H.K.</given-names></string-name>, <string-name><surname>Donayre</surname><given-names>A.</given-names></string-name>, <string-name><surname>Goldberg</surname><given-names>I.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia</article-title>. <source>Nature</source>. <year>2021</year>; <volume>590</volume>:<fpage>635</fpage>–<lpage>641</lpage>.<pub-id pub-id-type="pmid">33429418</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liao</surname><given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>G.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19</article-title>. <source>Nat. Med.</source><year>2020</year>; <volume>26</volume>:<fpage>842</fpage>–<lpage>844</lpage>.<pub-id pub-id-type="pmid">32398875</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chua</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Lukassen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Trump</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hennig</surname><given-names>B.P.</given-names></string-name>, <string-name><surname>Wendisch</surname><given-names>D.</given-names></string-name>, <string-name><surname>Pott</surname><given-names>F.</given-names></string-name>, <string-name><surname>Debnath</surname><given-names>O.</given-names></string-name>, <string-name><surname>Thurmann</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kurth</surname><given-names>F.</given-names></string-name>, <string-name><surname>Volker</surname><given-names>M.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis</article-title>. <source>Nat. Biotechnol.</source><year>2020</year>; <volume>38</volume>:<fpage>970</fpage>–<lpage>979</lpage>.<pub-id pub-id-type="pmid">32591762</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ward</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Aghaeepour</surname><given-names>N.</given-names></string-name>, <string-name><surname>Bhattacharyya</surname><given-names>R.P.</given-names></string-name>, <string-name><surname>Clish</surname><given-names>C.B.</given-names></string-name>, <string-name><surname>Gaudilliere</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hacohen</surname><given-names>N.</given-names></string-name>, <string-name><surname>Mansour</surname><given-names>M.K.</given-names></string-name>, <string-name><surname>Mudd</surname><given-names>P.A.</given-names></string-name>, <string-name><surname>Pasupneti</surname><given-names>S.</given-names></string-name>, <string-name><surname>Presti</surname><given-names>R.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Harnessing the potential of multiomics studies for precision medicine in infectious disease</article-title>. <source>Open Forum Infect. Dis.</source><year>2021</year>; <volume>8</volume>:<fpage>ofab483</fpage>.<pub-id pub-id-type="pmid">34805429</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lamers</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Haagmans</surname><given-names>B.L.</given-names></string-name></person-group><article-title>SARS-CoV-2 pathogenesis</article-title>. <source>Nat. Rev. Microbiol.</source><year>2022</year>; <volume>20</volume>:<fpage>270</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">35354968</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Merad</surname><given-names>M.</given-names></string-name>, <string-name><surname>Blish</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Sallusto</surname><given-names>F.</given-names></string-name>, <string-name><surname>Iwasaki</surname><given-names>A.</given-names></string-name></person-group><article-title>The immunology and immunopathology of COVID-19</article-title>. <source>Science</source>. <year>2022</year>; <volume>375</volume>:<fpage>1122</fpage>–<lpage>1127</lpage>.<pub-id pub-id-type="pmid">35271343</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olwal</surname><given-names>C.O.</given-names></string-name>, <string-name><surname>Nganyewo</surname><given-names>N.N.</given-names></string-name>, <string-name><surname>Tapela</surname><given-names>K.</given-names></string-name>, <string-name><surname>Djomkam Zune</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Owoicho</surname><given-names>O.</given-names></string-name>, <string-name><surname>Bediako</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Duodu</surname><given-names>S.</given-names></string-name></person-group><article-title>Parallels in sepsis and COVID-19 conditions: implications for managing severe COVID-19</article-title>. <source>Front. Immunol.</source><year>2021</year>; <volume>12</volume>:<fpage>602848</fpage>.<pub-id pub-id-type="pmid">33613574</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flerlage</surname><given-names>T.</given-names></string-name>, <string-name><surname>Boyd</surname><given-names>D.F.</given-names></string-name>, <string-name><surname>Meliopoulos</surname><given-names>V.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.G.</given-names></string-name>, <string-name><surname>Schultz-Cherry</surname><given-names>S.</given-names></string-name></person-group><article-title>Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract</article-title>. <source>Nat. Rev. Microbiol.</source><year>2021</year>; <volume>19</volume>:<fpage>425</fpage>–<lpage>441</lpage>.<pub-id pub-id-type="pmid">33824495</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hore</surname><given-names>V.</given-names></string-name>, <string-name><surname>Vinuela</surname><given-names>A.</given-names></string-name>, <string-name><surname>Buil</surname><given-names>A.</given-names></string-name>, <string-name><surname>Knight</surname><given-names>J.</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>M.I.</given-names></string-name>, <string-name><surname>Small</surname><given-names>K.</given-names></string-name>, <string-name><surname>Marchini</surname><given-names>J.</given-names></string-name></person-group><article-title>Tensor decomposition for multiple-tissue gene expression experiments</article-title>. <source>Nat. Genet.</source><year>2016</year>; <volume>48</volume>:<fpage>1094</fpage>–<lpage>1100</lpage>.<pub-id pub-id-type="pmid">27479908</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ashburner</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ball</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Blake</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Botstein</surname><given-names>D.</given-names></string-name>, <string-name><surname>Butler</surname><given-names>H.</given-names></string-name>, <string-name><surname>Cherry</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Dolinski</surname><given-names>K.</given-names></string-name>, <string-name><surname>Dwight</surname><given-names>S.S.</given-names></string-name>, <string-name><surname>Eppig</surname><given-names>J.T.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Gene ontology: tool for the unification of biology. The gene ontology consortium</article-title>. <source>Nat. Genet.</source><year>2000</year>; <volume>25</volume>:<fpage>25</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><collab>Gene Ontology, C.</collab><article-title>The gene ontology resource: enriching a GOld mine</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D325</fpage>–<lpage>D334</lpage>.<pub-id pub-id-type="pmid">33290552</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gillespie</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jassal</surname><given-names>B.</given-names></string-name>, <string-name><surname>Stephan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Milacic</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rothfels</surname><given-names>K.</given-names></string-name>, <string-name><surname>Senff-Ribeiro</surname><given-names>A.</given-names></string-name>, <string-name><surname>Griss</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sevilla</surname><given-names>C.</given-names></string-name>, <string-name><surname>Matthews</surname><given-names>L.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>C.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The reactome pathway knowledgebase 2022</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D687</fpage>–<lpage>D692</lpage>.<pub-id pub-id-type="pmid">34788843</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robinson</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>G.K.</given-names></string-name></person-group><article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>:<fpage>139</fpage>–<lpage>140</lpage>.<pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Phipson</surname><given-names>B.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Law</surname><given-names>C.W.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>W.</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>G.K.</given-names></string-name></person-group><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>e47</fpage>.<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chevrier</surname><given-names>S.</given-names></string-name>, <string-name><surname>Crowell</surname><given-names>H.L.</given-names></string-name>, <string-name><surname>Zanotelli</surname><given-names>V.R.T.</given-names></string-name>, <string-name><surname>Engler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Bodenmiller</surname><given-names>B.</given-names></string-name></person-group><article-title>Compensation of signal spillover in suspension and imaging mass cytometry</article-title>. <source>Cell Syst.</source><year>2018</year>; <volume>6</volume>:<fpage>612</fpage>–<lpage>620</lpage>.<pub-id pub-id-type="pmid">29605184</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Camilli</surname><given-names>C.</given-names></string-name>, <string-name><surname>Hoeh</surname><given-names>A.E.</given-names></string-name>, <string-name><surname>De Rossi</surname><given-names>G.</given-names></string-name>, <string-name><surname>Moss</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Greenwood</surname><given-names>J.</given-names></string-name></person-group><article-title>LRG1: an emerging player in disease pathogenesis</article-title>. <source>J. Biomed. Sci.</source><year>2022</year>; <volume>29</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">35062948</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Aging Atlas Consortium</collab></person-group><article-title>Aging atlas: a multi-omics database for aging biology</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D825</fpage>–<lpage>D830</lpage>.<pub-id pub-id-type="pmid">33119753</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wappett</surname><given-names>M.</given-names></string-name>, <string-name><surname>Harris</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lubbock</surname><given-names>A.L.R.</given-names></string-name>, <string-name><surname>Lobb</surname><given-names>I.</given-names></string-name>, <string-name><surname>McDade</surname><given-names>S.</given-names></string-name>, <string-name><surname>Overton</surname><given-names>I.M.</given-names></string-name></person-group><article-title>SynLeGG: analysis and visualization of multiomics data for discovery of cancer ‘Achilles heels’ and gene function relationships</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W613</fpage>–<lpage>W618</lpage>.<pub-id pub-id-type="pmid">33997893</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>S.H.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>P.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>A.N.</given-names></string-name>, <string-name><surname>Cho</surname><given-names>Y.C.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>Y.L.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F.H.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>DriverDBv3: a multi-omics database for cancer driver gene research</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D863</fpage>–<lpage>D870</lpage>.<pub-id pub-id-type="pmid">31701128</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arif</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Gungor</surname><given-names>C.</given-names></string-name>, <string-name><surname>Cakmak</surname><given-names>B.</given-names></string-name>, <string-name><surname>Arslanturk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tebani</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ozcan</surname><given-names>B.</given-names></string-name>, <string-name><surname>Subas</surname><given-names>O.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>iNetModels 2.0: an interactive visualization and database of multi-omics data</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W271</fpage>–<lpage>W276</lpage>.<pub-id pub-id-type="pmid">33849075</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Creasy</surname><given-names>H.H.</given-names></string-name>, <string-name><surname>Felix</surname><given-names>V.</given-names></string-name>, <string-name><surname>Aluvathingal</surname><given-names>J.</given-names></string-name>, <string-name><surname>Crabtree</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ifeonu</surname><given-names>O.</given-names></string-name>, <string-name><surname>Matsumura</surname><given-names>J.</given-names></string-name>, <string-name><surname>McCracken</surname><given-names>C.</given-names></string-name>, <string-name><surname>Nickel</surname><given-names>L.</given-names></string-name>, <string-name><surname>Orvis</surname><given-names>J.</given-names></string-name>, <string-name><surname>Schor</surname><given-names>M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>HMPDACC: a human microbiome project Multi-omic data resource</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D734</fpage>–<lpage>D742</lpage>.<pub-id pub-id-type="pmid">33305317</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ding</surname><given-names>J.</given-names></string-name>, <string-name><surname>Blencowe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nghiem</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ha</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.W.</given-names></string-name>, <string-name><surname>Li</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>X.</given-names></string-name></person-group><article-title>Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W375</fpage>–<lpage>W387</lpage>.<pub-id pub-id-type="pmid">34048577</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>W.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name></person-group><article-title>MVIP: multi-omics portal of viral infection</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D817</fpage>–<lpage>D827</lpage>.<pub-id pub-id-type="pmid">34718748</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Overmyer</surname><given-names>K.A.</given-names></string-name>, <string-name><surname>Shishkova</surname><given-names>E.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>I.J.</given-names></string-name>, <string-name><surname>Balnis</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bernstein</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Peters-Clarke</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>J.G.</given-names></string-name>, <string-name><surname>Quan</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Muehlbauer</surname><given-names>L.K.</given-names></string-name>, <string-name><surname>Trujillo</surname><given-names>E.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Large-Scale Multi-omic analysis of COVID-19 severity</article-title>. <source>Cell Syst.</source><year>2021</year>; <volume>12</volume>:<fpage>23</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">33096026</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sullivan</surname><given-names>K.D.</given-names></string-name>, <string-name><surname>Galbraith</surname><given-names>M.D.</given-names></string-name>, <string-name><surname>Kinning</surname><given-names>K.T.</given-names></string-name>, <string-name><surname>Bartsch</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Levinsky</surname><given-names>N.C.</given-names></string-name>, <string-name><surname>Araya</surname><given-names>P.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>K.P.</given-names></string-name>, <string-name><surname>Granrath</surname><given-names>R.E.</given-names></string-name>, <string-name><surname>Shaw</surname><given-names>J.R.</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>R.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The COVIDome explorer researcher portal</article-title>. <source>Cell Rep.</source><year>2021</year>; <volume>36</volume>:<fpage>109527</fpage>.<pub-id pub-id-type="pmid">34348131</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
